Large-scale testing (Phase 3)Active Not RecruitingNCT07284654
What this trial is testing
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49
Who this might be right for
Pneumococcal Vaccines
Vaxcyte, Inc. 4,049